Observational,cohort study in adults with chronic obstructive pulmonary disease treated with aclidinium, tiotropium, and other long-acting antagonist of lung M3 receptors (glycopyrronium and umeclidinium) in the United Kingdom.
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Aclidinium bromide (Primary) ; Glycopyrrolate; Tiotropium bromide; Umeclidinium
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Nov 2016 Status changed from not stated to completed.
- 07 Nov 2016 New trial record